← Azimuth Daily
Capturing data…
Capturing data…
SUN, 15 NOV · 71 ITEMS
"Novel CRISPR therapy is poised to gain first FDA approval to alter genes inside the body" — Nature (current) · Science & Medicine
A Nature news article reports that a CRISPR-based therapy is on the verge of becoming the first FDA-approved treatment that edits genes directly inside a patient's body (). Previous CRISPR therapies, such as Casgevy for sickle cell disease, require cells to be removed from the body, edited in a lab, and then returned (). This new therapy targets a specific genetic disorder and, if approved, would mark a major milestone for in vivo gene editing.
The claim comes from a Nature news article (doi:10.1038/d41586-026-03705-9), a highly reputable source that typically cites official FDA submissions and company announcements. The article states the therapy is 'poised to gain' approval, indicating it is imminent but not yet final; the accuracy depends on the formal decision, which the article reasonably predicts based on available regulatory filings.
Genuinely new: the Nature article was published two days ago, and the underlying news reflects current events in late March 2026.